EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms

Shuang Zhang, Na Yang, Ruoyu Mao iD, Ya Hao, Da Teng, Jianhua Wang iD

Antibiotics · 08.04.2024 · 13 (4) · 341

DOI: 10.3390/antibiotics13040341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.04.2024. Verfasst von Shuang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, 12 Zhongguancun Nandajie St., Haidian District, Beiji…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Innovation Program of Agricultural Science and Technology AMPs and Alternatives to Antibiotics for Animal Usage (ASTIP) in CAAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus pseudintermedius is an opportunistic pathogen commonly found in canines, and has garnered escalating interest due to its potential for zoonotic transmission and increasing antimicrobial resistance. However, the excessive use of antibiotics and the characteristic of S. pseudintermedius forming biofilms make treatment challenging. In this study, the in vivo and in vitro antimicrobial activity and mechanisms of action of NZ2114, a plectasin-derived peptide, against S. pseudintermedius were investigated. NZ2114 exhibited potent antibacterial activity towards S. pseudintermedius (minimum inhibitory concentration, MIC = 0.23 μM) with a lower probability of inducing drug-resistant mutations and efficient bactericidal action, which was superior to those of mopirucin (MIC = 0.25–0.5 μM) and lincomycin (MIC = 4.34–69.41 μM). The results of electron microscopy and flow cytometry showed that NZ2114 disrupted S. pseudintermedius’ cell membrane, resulting in cellular content leakage, cytoplasmic membrane shrinkage, and, eventually, cell death. The intracellular ROS activity and Alamar Blue detection showed that NZ2114 interferes with intracellular metabolic processes. In addition, NZ2114 effectively inhibits biofilm formation, and confocal laser scanning microscopy further revealed its antibacterial and anti-biofilm activity (biofilm thickness reduced to 6.90–17.70 μm). The in vivo therapy of NZ2114 in a mouse pyoderma model showed that it was better than lincomycin in effectively decreasing the number of skin bacteria, alleviating histological damage, and reducing the skin damage area. These results demonstrated that NZ2114 may be a promising antibacterial candidate against S. pseudintermedius infections.

Schlagwörter

Stichwörter der Autor:innen

Staphylococcus pseudintermediusantimicrobial peptide NZ2114biofilmmechanism of actionmouse pyoderma model

Autor:innen und Institutionen

  • Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, 12 Zhongguancun Nandajie St., Haidian District, Beijing 100081, China.
  • Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
  • Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China.

ORCID-Profile: Ruoyu Mao, Jianhua Wang

Förderung

  • the National Key Research and Development Program of China
  • the National Natural Science Foundation of China
  • the Innovation Program of Agricultural Science and Technology AMPs and Alternatives to Antibiotics for Animal Usage (ASTIP) in CAAS
  • The key project of the Innovation Program of Agricultural Science and Technology in CAAS
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Innovation Program of Agricultural Science and Technology: AMPs and Alternatives to Antibiotics for Animal Usage (ASTIP) in CAAS

Zitieren

APA

Zhang, S., Yang, N., Mao, R., Hao, Y., Teng, D., & Wang, J. (2024). In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms. Antibiotics, 13(4), 341. https://doi.org/10.3390/antibiotics13040341

Vancouver

Zhang S, Yang N, Mao R, Hao Y, Teng D, Wang J. In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms. Antibiotics. 2024;13(4):341. doi:10.3390/antibiotics13040341

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuang and Yang, Na and Mao, Ruoyu and Hao, Ya and Teng, Da and Wang, Jianhua},
  title = {In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms},
  journal = {Antibiotics},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {341},
  doi = {10.3390/antibiotics13040341}
}
Kostenlos starten →